AI assistant
CapsoVision, Inc — Director's Dealing 2025
Jul 7, 2025
33655_dirs_2025-07-07_953acada-9952-4fc5-af5c-39740fe24cfe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CapsoVision, Inc (CV)
CIK: 0001378325
Period of Report: 2025-07-03
Reporting Person: Tsai Chen Lung (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-03 | Common Stock | C | 91432 | — | Acquired | 115456 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | Series B Preferred Stock | $ | C | 71429 | Disposed | Common Stock (21450) | Indirect | |
| 2025-07-03 | Series D-1 Preferred Stock | $ | C | 55555 | Disposed | Common Stock (16683) | Indirect | |
| 2025-07-03 | Series E Preferred Stock | $ | C | 86956 | Disposed | Common Stock (26112) | Indirect | |
| 2025-07-03 | Series H Preferred Stock | $ | C | 90534 | Disposed | Common Stock (27187) | Indirect |
Footnotes
F1: Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.
F2: The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees.